Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing

British Journal of Cancer

Volumn 83, Issue 11, 2000, Pages 1462-1467

  Carozzi, F ^a   Ronco, G ^b   Confortini, M ^a   Noferini, D ^a   Maddau, C ^a   Ciatto, S ^a   Segnan, N ^b  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b ASL TO1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MARKER;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; GLOBIN GENE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 0033670018     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1491     Document Type: Article

References (36)

1. Present evidence on the value of HPV testing for cervical cancer screening: A model-based exploration of the (cost-) effectiveness
2. Matched case-control designs and overmatched analyses
3. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors
4. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high grade cervical lesions: A preliminary study on 1518 women
5. Intralaboratory reproducibility in cervical cytology. Results of the application of a 100-slide set
6. Human papillomavirus testing for primary cervical cancer screening
7. Human papillomavirus testing in primary cervical screening
8. HPV testing in primary screening of older women
9. Simultaneous detection and typing of genital human papilloma virus DNA using the polymerase chain reaction
10. Natural history of cervical neoplasia: Consistent results obtained by an identification technique
11. Optimisation of cervical cancer screening
12. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
13. Human Papillomaviruses
14. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia
15. Detection of human papillomavirus in cytologically normal women and subsequent cervical squamous intraepithelial lesions
16. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: Possible implications for cervical cancer screening
17. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by polymerase chain reaction, is age-dependent
18. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study
19. Relation of human papillomavirus to cervical lesions and consequences for cervical cancer screening: A prospective study
20. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer
21. A centralised cytologic screening programme for cervical cancer in Florence
22. A quality control system involving peer review of abnormal cervical smears
23. Should cervical cytology testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?
24. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
25. Screening. The next century
26. Processing long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction
27. Estimating sensitivity and specificity when repeated tests are performed on the same subject
28. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
29. Recent progress in defining the epidemiology of Human Papillomavirus infection and cervical neoplasia
30. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
31. Screening for cervical cancer: Prospects for the future
32. Risk factors for HPV detection in archival smears. A population based study from Greenland and Denmark
33. Human papillomavirus in false negative archival cervical smears: Implications for screening for cervical cancer
34. Type specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
35. HPV DNA testing of self-collected vaginal samples compare with cytologic screening to detect cervical cancer
36. Longitudinal analysis for discrete and continuous outcomes